Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

245 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
EpCAM (CD326) finding its role in cancer.
Baeuerle PA, Gires O. Baeuerle PA, et al. Br J Cancer. 2007 Feb 12;96(3):417-23. doi: 10.1038/sj.bjc.6603494. Epub 2007 Jan 9. Br J Cancer. 2007. PMID: 17211480 Free PMC article. Review.
Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer.
Schmidt M, Rüttinger D, Sebastian M, Hanusch CA, Marschner N, Baeuerle PA, Wolf A, Göppel G, Oruzio D, Schlimok G, Steger GG, Wolf C, Eiermann W, Lang A, Schuler M. Schmidt M, et al. Among authors: baeuerle pa. Ann Oncol. 2012 Sep;23(9):2306-2313. doi: 10.1093/annonc/mdr625. Epub 2012 Feb 21. Ann Oncol. 2012. PMID: 22357251 Clinical Trial.
On the abundance of EpCAM on cancer stem cells.
Gires O, Klein CA, Baeuerle PA. Gires O, et al. Among authors: baeuerle pa. Nat Rev Cancer. 2009 Feb;9(2):143; author reply 143. doi: 10.1038/nrc2499-c1. Epub 2009 Jan 9. Nat Rev Cancer. 2009. PMID: 19132011 No abstract available.
Nuclear signalling by tumour-associated antigen EpCAM.
Maetzel D, Denzel S, Mack B, Canis M, Went P, Benk M, Kieu C, Papior P, Baeuerle PA, Munz M, Gires O. Maetzel D, et al. Among authors: baeuerle pa. Nat Cell Biol. 2009 Feb;11(2):162-71. doi: 10.1038/ncb1824. Epub 2009 Jan 11. Nat Cell Biol. 2009. PMID: 19136966
245 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page